{"id":"https://openalex.org/W3084044657","doi":"https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-6-47","title":"Effects of the retinoic receptor agonists on proliferation of myelocytic leukemia cells","display_name":"Effects of the retinoic receptor agonists on proliferation of myelocytic leukemia cells","publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W3084044657","doi":"https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-6-47","mag":"3084044657"},"language":"en","primary_location":{"id":"doi:10.1254/jpssuppl.wcp2018.0_po4-6-47","doi":"https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-6-47","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-6-47","pdf_url":"https://www.jstage.jst.go.jp/article/jpssuppl/WCP2018/0/WCP2018_PO4-6-47/_pdf","source":{"id":"https://openalex.org/S4210239061","display_name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","issn_l":"2435-4953","issn":["2435-4953"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/jpssuppl/WCP2018/0/WCP2018_PO4-6-47/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041179989","display_name":"Takeaki Nitto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164131854","display_name":"Yokohama University of Pharmacy","ror":"https://ror.org/05s0z8a66","country_code":"JP","type":"education","lineage":["https://openalex.org/I164131854"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeaki Nitto","raw_affiliation_strings":["Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan","institution_ids":["https://openalex.org/I164131854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035176803","display_name":"Yasuko Ohnuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164131854","display_name":"Yokohama University of Pharmacy","ror":"https://ror.org/05s0z8a66","country_code":"JP","type":"education","lineage":["https://openalex.org/I164131854"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuko Ohnuki","raw_affiliation_strings":["Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan","institution_ids":["https://openalex.org/I164131854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018921522","display_name":"Tomoko Matsuda","orcid":"https://orcid.org/0000-0002-4709-4302","observed_orcids":["https://orcid.org/0000-0002-4709-4302"]},"institutions":[{"id":"https://openalex.org/I164131854","display_name":"Yokohama University of Pharmacy","ror":"https://ror.org/05s0z8a66","country_code":"JP","type":"education","lineage":["https://openalex.org/I164131854"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoko Matsuda","raw_affiliation_strings":["Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan","institution_ids":["https://openalex.org/I164131854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039156960","display_name":"Mizuki Saegusa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164131854","display_name":"Yokohama University of Pharmacy","ror":"https://ror.org/05s0z8a66","country_code":"JP","type":"education","lineage":["https://openalex.org/I164131854"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mizuki Saegusa","raw_affiliation_strings":["Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan","institution_ids":["https://openalex.org/I164131854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056718441","display_name":"Rina Matsuda","orcid":"https://orcid.org/0000-0002-8279-5788","observed_orcids":["https://orcid.org/0000-0002-8279-5788"]},"institutions":[{"id":"https://openalex.org/I164131854","display_name":"Yokohama University of Pharmacy","ror":"https://ror.org/05s0z8a66","country_code":"JP","type":"education","lineage":["https://openalex.org/I164131854"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Rina Matsuda","raw_affiliation_strings":["Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan","institution_ids":["https://openalex.org/I164131854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054231827","display_name":"Asako Tanaka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164131854","display_name":"Yokohama University of Pharmacy","ror":"https://ror.org/05s0z8a66","country_code":"JP","type":"education","lineage":["https://openalex.org/I164131854"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Asako Tanaka","raw_affiliation_strings":["Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan","institution_ids":["https://openalex.org/I164131854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038376263","display_name":"Kohei Sawaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164131854","display_name":"Yokohama University of Pharmacy","ror":"https://ror.org/05s0z8a66","country_code":"JP","type":"education","lineage":["https://openalex.org/I164131854"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kohei Sawaki","raw_affiliation_strings":["Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Japan","institution_ids":["https://openalex.org/I164131854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I164131854"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.20329821,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"WCP2018","issue":"0","first_page":"PO4","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/retinoic-acid-receptor-agonists","display_name":"retinoic acid receptor agonists","score":0.9649999737739563},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.9829999804496765},{"id":"https://openalex.org/keywords/tamibarotene","display_name":"tamibarotene","score":0.9950000047683716},{"id":"https://openalex.org/keywords/am580","display_name":"AM580","score":0.9480000138282776},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8659999966621399},{"id":"https://openalex.org/keywords/hl-60-cells","display_name":"HL-60 cells","score":0.9509999752044678},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.8769999742507935},{"id":"https://openalex.org/keywords/cyclin-a2","display_name":"cyclin A2","score":0.8169999718666077},{"id":"https://openalex.org/keywords/cyclin-d1","display_name":"cyclin D1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.984000027179718},{"id":"https://openalex.org/keywords/cd11b","display_name":"CD11b","score":0.859000027179718},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.7540000081062317}],"concepts":[{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.7268376350402832},{"id":"https://openalex.org/C2776601000","wikidata":"https://www.wikidata.org/wiki/Q612108","display_name":"Acute promyelocytic leukemia","level":4,"score":0.6135486364364624},{"id":"https://openalex.org/C120197328","wikidata":"https://www.wikidata.org/wiki/Q2838685","display_name":"Retinoic acid receptor","level":4,"score":0.5895892381668091},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5501582622528076},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5320283770561218},{"id":"https://openalex.org/C119775778","wikidata":"https://www.wikidata.org/wiki/Q18031040","display_name":"Retinoic acid receptor alpha","level":5,"score":0.517129123210907},{"id":"https://openalex.org/C2779963572","wikidata":"https://www.wikidata.org/wiki/Q29417","display_name":"Tretinoin","level":4,"score":0.4671480059623718},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.45388397574424744},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4334755539894104},{"id":"https://openalex.org/C162253465","wikidata":"https://www.wikidata.org/wiki/Q18031338","display_name":"Retinoid X receptor gamma","level":5,"score":0.41585367918014526},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.39224839210510254},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32025593519210815},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29368454217910767},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.263300359249115},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2621183395385742},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1254/jpssuppl.wcp2018.0_po4-6-47","doi":"https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-6-47","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-6-47","pdf_url":"https://www.jstage.jst.go.jp/article/jpssuppl/WCP2018/0/WCP2018_PO4-6-47/_pdf","source":{"id":"https://openalex.org/S4210239061","display_name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","issn_l":"2435-4953","issn":["2435-4953"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1254/jpssuppl.wcp2018.0_po4-6-47","doi":"https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-6-47","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-6-47","pdf_url":"https://www.jstage.jst.go.jp/article/jpssuppl/WCP2018/0/WCP2018_PO4-6-47/_pdf","source":{"id":"https://openalex.org/S4210239061","display_name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","issn_l":"2435-4953","issn":["2435-4953"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3084044657.pdf","grobid_xml":"https://content.openalex.org/works/W3084044657.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7166336725","https://openalex.org/W1972332894","https://openalex.org/W2556225500","https://openalex.org/W1817065479","https://openalex.org/W2024551869","https://openalex.org/W2166167582","https://openalex.org/W2989840913","https://openalex.org/W1687574083","https://openalex.org/W2389550230","https://openalex.org/W2559756057"],"abstract_inverted_index":{"All-trans":[0],"retinoic":[1,29,65],"acid":[2,30,66],"(ATRA)":[3],"is":[4],"used":[5],"to":[6,26,103],"treat":[7],"some":[8],"of":[9,59,108],"acute":[10,16],"myelocytic":[11],"leukemia":[12,18],"(AML)":[13],"such":[14],"as":[15,45,52,64,117],"promyelocytic":[17],"(APL).":[19],"Since":[20],"ATRA":[21,44],"shows":[22],"biological":[23],"activities":[24],"binding":[25],"its":[27],"receptor":[28,31,67],"(RAR),":[32],"we":[33],"compared":[34,69],"anti-proliferative":[35],"activity":[36],"against":[37],"AML":[38],"cell":[39],"line":[40],"HL-60":[41,72],"cells":[42,73,95],"between":[43],"pan-RAR":[46],"agonist":[47],"and":[48,50,61,79,88,114],"tamibarotene":[49,60,78],"Am580":[51,62,80],"RAR":[53],"alpha":[54],"agonist.":[55],"We":[56],"investigated":[57],"effects":[58],"synthesized":[63],"agonists":[68],"with":[70,76],"ATRA.":[71],"were":[74],"incubated":[75],"ATRA,":[77],"for":[81],"several":[82],"days.":[83],"Cell":[84],"number":[85],"was":[86,91,101],"counted":[87],"total":[89],"RNA":[90],"extracted":[92],"from":[93],"the":[94,97,105],"after":[96],"incubation.":[98],"Quantitative":[99],"RT-PCR":[100],"performed":[102],"quantify":[104],"mRNA":[106],"levels":[107],"cyclin":[109],"A2,":[110],"cyclinD1,":[111],"c-myc,":[112],"CD11b,":[113],"glyceraldehyde-3-phospahte":[115],"dehydrogenase":[116],"internal":[118],"control.":[119]},"counts_by_year":[],"updated_date":"2025-11-06T03:46:38.306776","created_date":"2020-09-14T00:00:00"}